STAT3 and cancer: Our collaborator (C. Lin, College of Pharmacy, OSU) has developed a small molecule, allosteric STAT3 inhibitor (LLL12) that exhibits broad activity against both human and canine cancer cell lines at concentrations in the nanomolar/low micromolar range [24, 50].